1. Home
  2. SION vs HY Comparison

SION vs HY Comparison

Compare SION & HY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • HY
  • Stock Information
  • Founded
  • SION 2019
  • HY 1991
  • Country
  • SION United States
  • HY United States
  • Employees
  • SION N/A
  • HY N/A
  • Industry
  • SION
  • HY Construction/Ag Equipment/Trucks
  • Sector
  • SION
  • HY Industrials
  • Exchange
  • SION NYSE
  • HY Nasdaq
  • Market Cap
  • SION 871.7M
  • HY 717.9M
  • IPO Year
  • SION 2025
  • HY N/A
  • Fundamental
  • Price
  • SION $16.92
  • HY $40.15
  • Analyst Decision
  • SION Strong Buy
  • HY Strong Buy
  • Analyst Count
  • SION 1
  • HY 1
  • Target Price
  • SION $32.00
  • HY $70.00
  • AVG Volume (30 Days)
  • SION 136.3K
  • HY 50.6K
  • Earning Date
  • SION 08-25-2025
  • HY 08-05-2025
  • Dividend Yield
  • SION N/A
  • HY 3.57%
  • EPS Growth
  • SION N/A
  • HY N/A
  • EPS
  • SION N/A
  • HY 5.60
  • Revenue
  • SION N/A
  • HY $4,162,100,000.00
  • Revenue This Year
  • SION N/A
  • HY N/A
  • Revenue Next Year
  • SION N/A
  • HY $2.55
  • P/E Ratio
  • SION N/A
  • HY $7.20
  • Revenue Growth
  • SION N/A
  • HY N/A
  • 52 Week Low
  • SION $7.26
  • HY $34.13
  • 52 Week High
  • SION $25.19
  • HY $84.44
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • HY 41.56
  • Support Level
  • SION N/A
  • HY $42.33
  • Resistance Level
  • SION N/A
  • HY $44.55
  • Average True Range (ATR)
  • SION 0.00
  • HY 1.23
  • MACD
  • SION 0.00
  • HY -0.18
  • Stochastic Oscillator
  • SION 0.00
  • HY 6.08

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

About HY Hyster-Yale Materials Handling Inc.

Hyster Yale Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally under the Hyster and Yale brand names. The Company has five segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni) and Nuvera Fuel Cells, LLC (Nuvera). Majority of revenue is from Lift Trucks. geographically operates in America, EMEA, JAPIC, maximum revenue from America.

Share on Social Networks: